According to Oyster Point Pharma's latest financial reports the company's current EPS (TTM) is -6,46ย โฌ. In 2021 the company made an earnings per share (EPS) of -3,76ย โฌ a decrease over its 2020 EPS that were of -2,84ย โฌ.